Doug Hampton 
DUBLIN, June 1, 2023 /PRNewswire/ — The “Advanced Renal Cell Carcinoma – Pipeline Insight, 2023” drug pipelines has been added to ResearchAndMarkets.com’s offering. This report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also … Read more
In recognition of securing high-caliber technology in manufacturing plasma derivatives and a track record of overseas plasma fractionation plant construction and technology transfer YONGIN, South Korea, June 1, 2023 /PRNewswire/ — GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesian Ministry of Health for … Read more
ROCKVILLE, Md. and SUZHOU, China, June 1, 2023 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and other major diseases, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, … Read more
SAN DIEGO, June 1, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life-threatening infectious diseases, today announced that Guy Cipriani, Senior Vice President and Chief Business Officer, and James Frakes, Chief Financial Officer, will present a company overview at the 13th … Read more
NEWTON, Mass., June 1, 2023 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an aggregate of 44,600 restricted stock units (RSUs) to eight newly-hired employees. These RSU awards were granted as of May 31, 2023 pursuant to the Company’s 2022 Inducement Stock … Read more
SAN DIEGO, June 1, 2023 /PRNewswire/ — Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, will participate at the Goldman Sachs 44th Annual Global Healthcare Conference 2023 on June 15 at 8:40 a.m. P.T. / 11:40 a.m. E.T. David Meek, chief executive officer, will represent the company in a fireside chat at the conference. … Read more
Strategic partnership to enhance patient care and access to critical medical services AURORA, Ore., June 1, 2023 /PRNewswire/ — Life Flight Network, the region’s leading air medical transport service, and Good Shepherd Health Care System (GSHCS), a renowned healthcare organization committed to providing exceptional patient care, are thrilled to announce that Life Flight Network’s new … Read more
ARLINGTON, Va., June 1, 2023 /PRNewswire/ — The National Alliance on Mental Illness (NAMI), the nation’s largest grassroots mental health organization, today launched “Mental Health Without Conditions,” a compassionate Pride Month campaign for LGBTQ+ dignity and equality. NAMI is accentuating its commitment to unconditional support for the LGBTQ+ community, calling for increased awareness and action … Read more
8th Annual “Eight Over Eighty” Benefit Gala Honors: Ron Carter, Letty Cottin Pogrebin, Erica Jong, Eve Queler, Sanford “Sandy” David Greenberg, Dr. Billy E. Jones, Peter May, Bruce McIver, and Stanley Pantowich Photos of the gala linked HERE NEW YORK, June 1, 2023 /PRNewswire/ — At its 8th annual Eight Over Eighty gala, health care, … Read more
DUBLIN, June 1, 2023 /PRNewswire/ — The “Drug Discovery Services Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the market. The global drug discovery services market is expected to grow from $14.22 billion in 2022 to … Read more